TheraJect


TheraJect, Inc. is a manufacturing stage biopharmaceutical company dedicated to drug delivery including vaccines via dissolving microneedle transdermal technology. The company focuses on enhancing the efficacy of existing vaccines, enabling new vaccines, and expanding the global market. Their innovative microneedle patches create superficial pathways through the skin to deliver drugs or vaccines painlessly and without sharps waste, using materials that are generally regarded as safe (GRAS). They aim to provide effective, safe, and easy-to-use delivery systems that can be manufactured at scale and stored without cold chain requirements.

Industries

biotechnology
health-care
pharmaceutical

TheraJect

Fremont, California, United States, North America


Products

Dissolving microneedle transdermal patch

A patch containing an array of dissolving microneedles that deliver drugs, vaccines or genetic materials into the viable epidermis when applied to the skin; needles dissolve in interstitial fluid and are held by an adhesive patch.


Services

Development and manufacturing of dissolving microneedle patches

Development, prototyping and scalable manufacturing processes for dissolving microneedle transdermal patches for drug and vaccine delivery.

Expertise Areas

  • Transdermal microneedle delivery
  • Vaccine and biologic formulation for patch delivery
  • Microfabrication and mold-based production
  • Scale-up manufacturing of medical patches
  • Show More (4)

Key Technologies

  • Dissolving microneedle arrays
  • Hydrogel-based microneedle formulation
  • Mold casting microfabrication
  • Ambient-temperature drying processes
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.